Abstract:The prevalence of arterial hypertension, particularly systolic hypertension, is constantly rising worldwide. This is mainly the clinical expression of arterial stiffening as a result of the population's aging. Chronic elevation in blood pressure represents a major risk factor not only for cardiovascular morbidity and mortality but also for cognitive decline and loss of autonomy later in life. Clinical evidence obtained in community-dwelling older people with few comorbidities and preserved autonomy supports the beneficial effects of lowering blood pressure in older hypertensive subjects even after the age of 80 years. However, observational studies in frail older individuals treated for hypertension have shown higher morbidity and mortality rates compared with those with lower blood pressure levels. Clearly, in very old subjects, the therapeutic strategy of one size fits all cannot be applied because of the enormous functional heterogeneity in these individuals. Geriatric medicine proposes taking into account the function/frailty/autonomy status of older people. In the present review, we propose to adapt the antihypertensive treatment using an easy-to-apply visual numeric scale allowing the identification of 3 different patient profiles according to the functional status and autonomy for activities of daily living. For the preserved function profile, strategies should be those proposed for younger old adults. For the loss of function/preserved activities of daily living' profile, a more detailed geriatric assessment is needed to define the benefit/risk balance as well as requirements for the tailoring of the various therapeutic strategies. Lastly, for the loss of function and altered activities of daily living' profile, therapeutic strategies should be thoroughly reassessed, including deprescribing (when considered appropriate). In the near future, controlled trials are necessary for the most frail older subjects (ie, in those systematically excluded from previous clinical trials) to gain stronger evidence regarding the benefits of the various therapeutic strategies.

Hypertension and Age-Related Cognitive Impairment: Common Risk Factors and a Role for Precision Aging

Hypertension-induced cognitive impairment: from pathophysiology to public health

Hypertension, Neurovascular Dysfunction, and Cognitive Impairment

Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden

Hypertension and Mild Cognitive Impairment: State-of-the-Art Review

Hypertension and Cognitive Impairment: A Review of Mechanisms and Key Concepts

Blood Pressure Control and Protection of the Aging Brain

Blood Pressure and Cognitive Function in Older Adults

Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers

Age‐related changes in cerebrovascular health and their effects on neural function and cognition: A comprehensive review

Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention

Association of Hypertension with Different Cognitive Disorders

Vascular Risk Factors and Brain Health in Aging: Insights from a Community-Based Cohort Study

Aging as a target for the prevention and treatment of Alzheimer's disease

Horizons in Human Aging Neuroscience: From Normal Neural Aging to Mental (Fr)Agility

Aging precisely: Precision medicine through the lens of an older adult

Hypertension Management in Older and Frail Older Patients

A Translational Perspective on the Interplay Between Hypertension, Inflammation and Cognitive Impairment

A lifetime perspective on risk factors for cognitive decline with a special focus on early events

The Impact of Hypertension on Cognitive Decline and Alzheimer's Disease and Its Management: A Systematic Review

Antihypertensive medications and dementia in older adults with hypertension